Screener
West Pharmaceutical Services WST Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026.
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation | 90.3 | 79.9 |
| Amortization | 1.1 | 1.5 |
| Stock-based compensation | 17.5 | 8.7 |
| Non-cash restructuring charges | 1.9 | 1.6 |
| Asset impairments | 4.2 | 4.1 |
| Other non-cash items, net | (5.0) | (6.9) |
| Changes in assets and liabilities | (188.9) | (4.0) |
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is West Pharmaceutical Services's compensation and benefits?
- West Pharmaceutical Services (WST) reported compensation and benefits of $10.9M in Q2 2026.
- How has West Pharmaceutical Services's compensation and benefits changed year-over-year?
- West Pharmaceutical Services's compensation and benefits increased by 47.3% year-over-year, from $7.4M to $10.9M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about West Pharmaceutical Services's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude